This becomes apparent in the fact that the PGC-1α-NRF-1/2-TFAM pathway is downregulated in many neurodegenerative diseases including Parkinson’s disease (PD), Huntington’s disease (HD) and Alzheimer’s disease (AD) [11,134,135]. Here, TFAM is linked to Alzheimer disease.